These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24607562)

  • 21. Impact of diurnal temperature variations on sputum bacterial detection in hospitalized patients with acute COPD exacerbation: a retrospective study from Fuzhou, China.
    Xue H; Xue Q; Wang C; Chen Q; Wang D; Li Z; Xie B; Zheng W
    BMC Pulm Med; 2024 Jun; 24(1):291. PubMed ID: 38909192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
    Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
    J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upper-respiratory viral infection, biomarkers, and COPD exacerbations.
    Kherad O; Kaiser L; Bridevaux PO; Sarasin F; Thomas Y; Janssens JP; Rutschmann OT
    Chest; 2010 Oct; 138(4):896-904. PubMed ID: 20435659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
    Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
    Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbiological study of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and the usefulness of analytical and clinical parameters in its identification (VIRAE study).
    Boixeda R; Rabella N; Sauca G; Delgado M; Martínez-Costa X; Mauri M; Vicente V; Palomera E; Serra-Prat M; Capdevila JA
    Int J Chron Obstruct Pulmon Dis; 2012; 7():327-35. PubMed ID: 22745532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of exacerbation frequency of AECOPD based on next-generation sequencing and its relationship with imbalance of lung and gut microbiota: a protocol of a prospective cohort study.
    Deng L; Yan J; Xu H; Huang C; Lv Y; Wu Q; Xu Y; Chen X
    BMJ Open; 2021 Sep; 11(9):e047202. PubMed ID: 34475159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sputum colour as a marker for bacteria in acute exacerbations of COPD: protocol for a systematic review and meta-analysis.
    Spies R; Potter M; Hollamby R; van der Walt S; Hohlfeld A; Ochodo E; van Zyl-Smit RN
    Syst Rev; 2021 Jul; 10(1):211. PubMed ID: 34315541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study.
    Planquette B; Péron J; Dubuisson E; Roujansky A; Laurent V; Le Monnier A; Legriel S; Ferre A; Bruneel F; Chiles PG; Bedos JP
    Int J Chron Obstruct Pulmon Dis; 2015; 10():379-88. PubMed ID: 25733827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.
    Estirado C; Ceccato A; Guerrero M; Huerta A; Cilloniz C; Vilaró O; Gabarrús A; Gea J; Crisafulli E; Soler N; Torres A
    Respir Res; 2018 Jun; 19(1):119. PubMed ID: 29907113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].
    Jiang M; Ma JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptococcus pneumoniae urinary antigen test and acute exacerbations of chronic obstructive pulmonary disease.
    Nishimura K; Nishimura T; Oga T
    COPD; 2012 Aug; 9(4):344-51. PubMed ID: 22452423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD.
    Leung JM; Tiew PY; Mac Aogáin M; Budden KF; Yong VF; Thomas SS; Pethe K; Hansbro PM; Chotirmall SH
    Respirology; 2017 May; 22(4):634-650. PubMed ID: 28342288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations.
    Calderazzo MA; Trujillo-Torralbo MB; Finney LJ; Singanayagam A; Bakhsoliani E; Padmanaban V; Kebadze T; Aniscenko J; Elkin SL; Johnston SL; Mallia P
    Int J Chron Obstruct Pulmon Dis; 2019; 14():823-832. PubMed ID: 31114182
    [No Abstract]   [Full Text] [Related]  

  • 34. Time-course of upper respiratory tract viral infection and COPD exacerbation.
    Stolz D; Papakonstantinou E; Grize L; Schilter D; Strobel W; Louis R; Schindler C; Hirsch HH; Tamm M
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31391222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of salvational intervention with ICS/LABA for reducing chronic obstructive pulmonary disease exacerbation under severe air pollution (SIRCAP) in Beijing: protocol of a multi-center randomized controlled trial.
    Zhou T; Zhong Y; Liao J; Wang G; Li X; Qian X; Xiang P; Chen X; Xu Z; Zhang F; Wang X; Wang S; Li X; Yu C; Zhang Y; Xia G; Dai L
    BMC Pulm Med; 2019 Jan; 19(1):22. PubMed ID: 30683080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
    Su YC; Jalalvand F; Thegerström J; Riesbeck K
    Front Immunol; 2018; 9():2530. PubMed ID: 30455693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of bacterial strain acquisition in the lung of patients with COPD: the AERIS study.
    Malvisi L; Yarraguntla A; Mortier MC; Osman K; Cleary DW; Sente B; Pascal TG; Weynants V; Clarke SC; Taddei L; Wilkinson TMA; Devaster JM; Devos N;
    Infect Dis (Lond); 2022 Nov; 54(11):784-793. PubMed ID: 35794793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
    Wu Y; Luo Z; Liu C
    Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Sputum Proteomic Signature That Associates with Increased IL-1β Levels and Bacterial Exacerbations of COPD.
    Damera G; Pham TH; Zhang J; Ward CK; Newbold P; Ranade K; Sethi S
    Lung; 2016 Jun; 194(3):363-9. PubMed ID: 27083436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and clinical implications of respiratory viruses in stable chronic obstructive pulmonary disease (COPD) and exacerbations: a systematic review and meta-analysis protocol.
    Kefala AM; Fortescue R; Alimani GS; Kanavidis P; McDonnell MJ; Magiorkinis E; Megremis S; Paraskevis D; Voyiatzaki C; Mathioudakis GA; Papageorgiou E; Papadopoulos NG; Vestbo J; Beloukas A; Mathioudakis AG
    BMJ Open; 2020 Apr; 10(4):e035640. PubMed ID: 32269027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.